From multislice CT to whole-body biomarker imaging in lymphoma patients

Bazelaire, Cédric de; Kerviler, É. de

doi:10.1007/s00330-010-2035-9

Cited by 6 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The current imaging technique of choice for treatment response assessment in HL is positron emission tomography (PET) after injection of F-18-fludeoxyglucose (FDG), which reflects tissue glycolysis. [4][5][6][7][8][9][10][11] Combined with computed tomography (CT), PET/CT provides both metabolic and anatomic informations. However, PET and PET/CT devices are typically only installed at tertiary care centers, which leads to long waiting lists, and thus, a possible delay in therapy.…”

Section: Introductionmentioning

confidence: 99%

Three‐dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: Comparison with F‐18‐FDG PET

et al. 2014

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Three‐dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: Comparison with F‐18‐FDG PET

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Таким образом, биологические ткани разделены на отсеки. Кроме того, химическое взаимодействие молекул воды и макромолекул влияет на процесс диффузии [2,4].…”

unclassified

“…( 2004), Padhani c соавт. (2011), у пациентов с лимфомой терапия может вызывать изменения интенсивности сигнала костного мозга на изображениях с ДВ МРТ -в процессе химиотерапии интенсивность сигнала снижается, а использование во время лечения факторов роста стимулирует костный мозг, что приводит к увеличению интенсивности сигнала [4,14,25].…”

unclassified

Diffusion-Weighted Magnetic Resonance Imaging for Non-Hodgkin’s Lymphomas. Literature Review and Own Clinical Experience

Алексеев,

Троян,

Рукавицын

et al. 2023

Гематология. Трансфузиология. Восточная Европа

View full text Add to dashboard Cite

Данный литературный обзор посвящен анализу возможностей применения одного из современных доступных методов лучевой диагностики у пациентов с неходжкинскими лимфомами для оценки лечения и выявления рецидива заболевания. Это метод диффузионно-взвешенной магнитно-резонансной томографии всего тела (ДВ МРТ), который набирает популярность и является возможной альтернативой использующимся традиционным методам, таким как КТ и ПЭТ/КТ с 18F-ФДГ. В обзоре обсуждаются не только преимущества метода, но также недостатки и подводные камни, с которыми приходится сталкиваться врачу-диагносту. This literature review is devoted to analyzing the possibilities of using one of the modern available methods of radiodiagnosis in patients with non-Hodgkin lymphoma to evaluate treatment and detect relapse of the disease. This is a whole-body diffusion-weighted magnetic resonance imaging (DWMRI) technique that is gaining popularity and is a possible alternative to current conventional techniques such as CT and 18F-FDG PET/CT. The review discusses not only the advantages of the method, but also the disadvantages and pitfalls that the diagnostician has to face.

show abstract

“…16 Using this principle, diffusion MRI can detect tumor-related changes that are not limited to anatomical information. 17 Furthermore, apparent diffusion coefficient (ADC) quantification on DWI can provide useful information on treatment response and help distinguish benign from malignant lymph nodes. 18 Over the last decade, a growing number of studies have compared WB-MRI and FDG-PET/CT in patients with lymphoma, using a variety of approaches.…”

Section: Introductionmentioning

confidence: 99%

Whole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studies

et al. 2015

View full text Add to dashboard Cite

CONTEXT AND OBJECTIVE: Positron emission tomography with [18]F-fluoro-2-deoxyglucose (FDG-PET/CT) has been advocated as the method of choice for lymphoma staging, since it enables whole-body analysis with high sensitivity for detection of affected areas and because it combines capacities for anatomical and functional assessment. With technological advances, magnetic resonance imaging (MRI) has emerged as an alternative to FDG-PET/CT. This systematic review with meta-analysis aimed to compare whole-body diffusion-weighted MRI (WB-MRI) with FDG-PET/CT for lymphoma staging. DESIGN AND SETTING: Systematic review on diagnostic test accuracy studies conducted at a public university. METHODS: The Medline, Scopus, Embase and Lilacs databases were searched for studies published up to September 2013 that compared WB-MRI and FDG-PET/CT for lymphoma staging. The reference lists of included studies were checked for any relevant additional citations. RESULTS: Six studies that evaluated the initial lymphoma staging in 116 patients were included. WB-MRI and FDG-PET/CT agreed in 90.5% of the cases (κ = 0.871; P < 0.0001). In most of the studies, when there was disagreement between the methods, WB-MRI overstaged in relation to FDG-PET/CT. The sensitivity of WB-MRI and FDG-PET/CT, in comparison with the clinical-radiological standard, ranged from 59 to 100% and from 63 to 100% respectively. CONCLUSION: WB-MRI is a highly sensitive method for initial lymphoma staging. It has excellent agreement with FDG-PET/CT and is a great alternative for managing lymphoma patients, without using ionizing radiation or an intravenous contrast agent.

show abstract

From multislice CT to whole-body biomarker imaging in lymphoma patients

Cited by 6 publications

References 13 publications

Three‐dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: Comparison with F‐18‐FDG PET

Three‐dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: Comparison with F‐18‐FDG PET

Diffusion-Weighted Magnetic Resonance Imaging for Non-Hodgkin’s Lymphomas. Literature Review and Own Clinical Experience

Whole-body diffusion-weighted magnetic resonance imaging versus FDG-PET/CT for initial lymphoma staging: systematic review on diagnostic test accuracy studies

Contact Info

Product

Resources

About